Alessandro Lucchesi: Engineering Disease Trajectories in Myeloproliferative Neoplasms at RiseMPN 2026
Alessandro Lucchesi, Consultant Hematologist at Romagna Scientific Institute for the Study and Treatment of Cancer (I.R.S.T.) Ltd., shared a post on LinkedIn:
“Tomorrow morning, in Rome, RiseMPN 2026 begins.
Two days. One room. One question:
Can we engineer disease trajectories in myeloproliferative neoplasms?
More than 50 faculty from 11 countries, across Europe and the United States. Ten sessions, two Rise Lectures, a transatlantic dialogue on myelofibrosis, the voice of patients, and the young investigators who will present their work at the Poster Walk.
We are proud to be endorsed by SIIAM – Italian Society of Artificial Intelligence in Medicine, GITMO, AIPAMM, ERN-EuroBloodNet (European Reference Network on Rare Hematological Diseases) and FNOB – National Federation of Orders of Biologists.
None of this happens without the people behind it: the faculty who said yes, the Scientific Committee, IRCCS Romagna Institute for the Study of Tumors ‘Dino Amadori’ (IRST), Francesca Mazza and the team at Xenia. Thank you.
See you tomorrow. And for those who cannot be there, we will share the key messages here.”
Stay updated with Hemostasis Today.
-
Nov 6, 2026, 22:24Davood Bava: A New Practical Handbook for Advances in Transfusion Medicine
-
Nov 6, 2026, 22:15Dmitrii Kalinin: Allosteric Anticoagulation – An Alternative Strategy for Safer, Next-Generation Anticoagulants
-
Nov 6, 2026, 15:11Sophia Delicou: Discussing Real World Mitapivat Case Studies at the 37th Panhellenic Hematology Congress
-
Nov 6, 2026, 14:57Rahul Thakur: Pretransplant Biomarkers Linked to Post Transplant GVHD and Survival at ASH 2026
-
Nov 6, 2026, 14:46ASH 2026 Outlines Visa Guidance and Flexible Registration for International Attendees
-
Nov 6, 2026, 14:39Ney Carter Borges: Intensive LDL-C Lowering and Coronary Plaque Regression
-
Nov 6, 2026, 14:34William Wallace: Visceral Fat Drives the Broadest Inflammatory Protein Signature Among Cardiometabolic Traits
-
Nov 6, 2026, 14:28Akshat Jain: Completing a Milestone Speaker Circuit with Gene Therapy and VWD Presentations at ASH 2026
-
Nov 6, 2026, 14:23Anirban Sen Gupta: Bridging Therapeutics and Diagnostics for the Future of Precision Transfusion